eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Moorfields Pharmaceuticals
25 Provost Street, London, N1 7NH
Telephone: +44 (0)207 684 9090
Fax: +44 (0)207 502 2332
WWW: http://www.moorfieldspharmaceuticals.co.uk
Medical Information e-mail: pharmaceuticals@moorfields.nhs.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 20/12/2011
SPC Ilube Eye Drops

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 6. 5 - Nature and Contents of Container
Updated on 15/07/2011 and displayed until 20/12/2011
Reasons for adding or updating:
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.7 - Effects on Ability to Drive and Use Machines
  • Change to section 4.8 - Undesirable Effects
Updated on 07/02/2011 and displayed until 15/07/2011
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
  • Change of Marketing Authorisation Holder
  • Product Acquisition
Updated on 06/01/2009 and displayed until 07/02/2011
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Updated on 26/11/2003 and displayed until 06/01/2009
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
Updated on 04/09/2003 and displayed until 26/11/2003
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 10/07/2001 and displayed until 04/09/2003
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 22/06/2001 and displayed until 10/07/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 22/06/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  acetylcysteine